ABG
GOSS icon

Ally Bridge Group’s Gossamer Bio GOSS Stock Holding History

Ally Bridge Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,713
Closed -$4.52M – 35
2022
Q3 		$4.52M Sell
4,713
-4,037
-46% -$4.01M 2.98% 14
2022
Q2 		$5.86M Buy
8,750
+3,125
+56% +$1.94M 5.34% 7
2022
Q1 		$3.91M Sell
5,625
-313
-5% -$241K 2.9% 16
2021
Q4 		$5.37M Sell
5,938
-8,750
-60% -$8.31M 1.88% 23
2021
Q3 		$14.8M Hold
14,688
– – 4.34% 10
2021
Q2 		$9.5M Buy
+14,688
New +$10.2M 2.37% 22

Other funds holding GOSS

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HHLR Advisors
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Weiss Asset Management
Weiss Asset Management Boston, Massachusetts $9.5B AUM 55.06% 1-Year Est. Return
NEA Management Company
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Boxer Capital
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ally Bridge Group's GOSS Position: Q4 2022 in Review

Ally Bridge Group sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 4,713 shares — an estimated $4.52M sold.

Ally Bridge Group first reported a position in GOSS in Q2 2021 and held it in 6 quarters. The position peaked at $14.8M in Q3 2021. 118 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Ally Bridge Group reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Ally Bridge Group sold 4,713 Gossamer Bio shares in Q4 2022, an estimated $4.52M.
  • Ally Bridge Group first reported a position in Gossamer Bio in Q2 2021 and held it in 6 quarters.
  • Ally Bridge Group's Gossamer Bio position peaked at $14.8M in Q3 2021.
  • 118 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Ally Bridge Group's 13F filing for Q4 2022, filed 14 Feb 2023.